Cartesian Therapeutics
RNAC
RNAC
29 hedge funds and large institutions have $106M invested in Cartesian Therapeutics in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+13
Holders Change %
+81.25%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $6K | +$6K | +14 | New |
|
27
Bank of America
Charlotte,
North Carolina
| $3K | +$3K | +6 | New |
|
28
BNP Paribas Financial Markets
Paris,
France
| $2.61K | +$2.61K | +6 | New |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1K | +3 | New |
|
|
SSA
30
Schonfeld Strategic Advisors
New York
| – | -$656K | -1,562 | Closed |
|
31
Marshall Wace
London,
United Kingdom
| – | -$506K | -1,207 | Closed |
|
32
Millennium Management
New York
| – | -$358K | -852 | Closed |
|
|
MIM
33
Monashee Investment Management
Boston,
Massachusetts
| – | -$350K | – | – |
|